Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model
Journal of Hepato-Biliary-Pancreatic Sciences · 2024
DOI: 10.1002/jhbp.12046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Daisuke Miyamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Disease Models, Animal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background
Numerous chemical reprogramming techniques have been reported, rendering them applicable to regenerative medicine research. The aim of our study was to evaluate the therapeutic potential of human CLiP derived from clinical specimens transplanted into a nonalcoholic steatohepatitis (NASH) mouse model of liver fibrosis.
Methods
We successfully generated chemically induced liver progenitor (CLiP), which exhibited progenitor‐like characteristics, through stimulation with low‐molecular‐weight compounds. We elucidated their cell differentiation ability and therapeutic effects. However, the therapeutic efficacy of human CLiP generated from clinical samples on liver fibrosis, such as liver cirrhosis, remains unproven.
Results
Following a 4 week period, transplanted human CLiP in the NASH model differentiated into mature hepatocytes and demonstrated suppressive effects on liver injury markers (i.e., aspartate transaminase and alanine transaminase). Although genes related to inflammation and fat deposition did not change in the human CLiP transplantation group, liver fibrosis‐related factors (Acta2 and Col1A1) showed suppressive effects on gene expression following transplantation, with approximately a 60% reduction in collagen fibers. Importantly, human CLiP could be efficiently induced from hepatocytes isolated from the cirrhotic liver, underscoring the feasibility of using autologous hepatocytes to produce human CLiP.
Conclusion
Our findings demonstrate the effectiveness of human CLiP transplantation as a viable cellular therapy for liver fibrosis, including NASH liver. These results hold promise for the development of liver antifibrosis therapy utilizing human CLiP within the field of liver regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Clinical Laboratory, NHO Nagasaki Medical Center, Nagasaki, Japan.
- Department of Molecular Cell Therapy Research, Medical Research Institute, Tokyo Medical University, Tokyo, Japan.
- Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Hematology, Atomic Bomb Disedase Institute, Nagasaki University, Nagasaki, Japan.
ORCID-Profile: Daisuke Miyamoto, Akihiko Soyama, Susumu Eguchi
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Miyamoto, D., Matsuguma, K., Nagai, K., Miyoshi, T., Hara, T., Matsushima, H., Soyama, A., Ochiya, T., Miyazaki, Y., & Eguchi, S. (2024). Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12046
Vancouver
Miyamoto D, Matsuguma K, Nagai K, Miyoshi T, Hara T, Matsushima H, et al. Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.12046
BibTeX
@article{Miyamoto2024,
author = {Miyamoto, Daisuke and Matsuguma, Kunihito and Nagai, Kazuhiro and Miyoshi, Takayuki and Hara, Takanobu and Matsushima, Hajime and Soyama, Akihiko and Ochiya, Takahiro and Miyazaki, Yasushi and Eguchi, Susumu},
title = {Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2024},
doi = {10.1002/jhbp.12046}
}
EUVIMED